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Summary In this review of the literature devoted to the use of honey, the authors analyse the
composition, indications, beneﬁts and adverse effects of this product in otorhinolaryngology
and head and neck surgery. Published data indicate that honey applied topically to skin and
mucosal wounds and/or burns and administered orally as antitussive medication (after the ﬁrst
year of life) is highly effective with no adverse effects. The physiological action of honey is
the result of various mechanisms (osmotic, detersion, bactericidal action). Various medicinal
honeys are available worldwide, but only one has Food and Drug Administration approval for
the treatment of wounds. After the ﬁrst year of life, the use of food honey appears to be as
effective as medicinal honey, while decreasing the overall cost of treatment.
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Introduction
Religious texts describe honey as a great gift to mankind
(Table 1) and honey has been used for medicinal purposes
for more than 4000 years [1]. Sumerian tablets dating from
2100 B.C. describe the use of honey in various recipes and
dressings [1]. About 500 remedies are also described in
the Smith, Ebers and Kahum papyruses written in Egypt
between 2000 and 1000 B.C. [1]. In India, at the same period,
Ayurvedic physicians considered that honey acted on the
essential elements (air, ﬁre, bile and circulation) that deter-
mine man’s equilibrium and Susrhuta, a surgeon of the time,
advised coating honey mixed with butter to an infected ear
lobe after piercing [1].
Hippocrates prescribed honey for burns, boils and
abscesses, while Dioscorides, a physician of the Roman army
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n 50 B.C., used honey to treat wounds and inﬂammation
f the throat and tonsils [1]. In the Hippocratic Corpus,
oney is mentioned 542 times (particularly in the treatise
n gynaecology and internal diseases, but also for pleurisy,
iseases of the ileum, as a suppository for haemorrhoids, or
y application to the eye and on wounds) and notes that:
. .‘‘wine and honey are wonderfully adapted to man; both
n health and in disease, they are administered wisely and
ustly according to the individual constitution’’ [2]. Finally,
alen, in De Naturalibus Facultatibus, wrote that honey
s ‘‘. . . excellent for the elderly, but harmful to the hot
empered. . .’’ [2].
However, the ﬁrst modern scientiﬁc article devoted to
he healing properties of honey was only published in
936 [3] and although the literature devoted to honey has
ontinued to grow, with more than 920,000 hits on the
oogle search engine in 2010 for the combination of
‘honey’’ and ‘‘treatment’’, to our knowledge, no article
as been published on this subject in the French otorhi-
olaryngology literature. In view of this lack of data, the
uthors decided to review the medical literature (PubMed
served.
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Table 1 Honey in religious texts.
Origin Quotation
Homeric hymn to hermes ‘‘. . . yellow honey. . . the gods’ sweet food. . .’’
The Bible
Psalm119: verse 103 ‘‘How sweet are Your words to my taste, sweeter than honey to my mouth’’
Exodus 33: 8 ‘‘And I am come down to deliver them out of the hand of the Egyptians, and to
bring them up out of that land unto a good land and a large, unto a land ﬂowing
with milk and honey...’’
Koran
Sourate 16: verses 68—69 ‘‘And your Lord inspired the bees, saying: ‘Take you habitations in the mountains
and in the trees and in what they erect.
Then, eat of all fruits, and follow the ways of your Lord made easy (for you).’
There comes forth from their bellies, a drink of varying colour wherein is healing
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earch), and study the composition, mechanism of action,
ndications and adverse effects of honey in otorhinolaryn-
ology as well as the future prospects of this gift of the
ods.
omposition of honey
oney is an acidic product (pH 4) with a variable chemi-
al composition according to the ﬂowers from which it is
erived. On average, it is composed of about 80% sugars
glucose, fructose, sucrose, levulose, maltose, sucrose), 17
o 20% water, and 4% of various other substances (pollen
rains, proteins, enzymes, hydrogen peroxide, amino acids,
rganic acids, polyphenols, vitamins (except for vitamin A),
inerals, and more than 100 volatile substances (alcohols,
sters, aromatic substances) [1]. The low water concentra-
ion of honey helps to prevent the growth of micro-organisms
yeasts, fungi, bacteria), but as this product is hygroscopic,
hen left in contact with air for several months, its relative
umidity increases to more than 50%, resulting in fermenta-
ion [1].
The composition of honey varies according to its source,
he harvest season, the plants from which nectar is
athered, the modalities of honey collection and storage. As
oney is produced by bees, which collect dust deposited on
lants during pollen gathering, honey is subject to various
otential sources of contamination. The best-known form
f contamination is that due to the pesticides, antibiotics
nd acaricides used by beekeepers and farmers. However,
he quantities of these contaminants are very small and
elow the limits accepted by the international literature
4]. Contamination by Caesium (134 and 137) mainly affects
eather honey and is due to atmospheric nuclear tests
nd the Chernobyl accident. Finally, honey is not sterile
nd can contain bacteria (B. subtilis and C. botulinum). In
005, Nevas et al. [5], in an analysis of 235 types of honey
aken from hives in Nordic countries (Denmark, Norway,
weden), demonstrated the presence of Clostridium
otulinum (serotypeA, B, E or F) with an incidence ranging
rom 2 to 26% depending on the country. However, honey can
e sterilized by gamma radiation (2.5 cGy) without loosing
ts biological properties [6].
t
h
N
ts indeed a sign for people who think.’’
iological effects
he two main biological effects of honey are its antisep-
ic and healing properties. These properties are classically
ttributed to two factors: hydrogen peroxide (H2O2) and
yperosmolarity [7,8]. The H2O2 present in honey acts as
detergent in relation to bacteria present in the wound.
he hyperosmolarity of honey, induced by its very high sugar
ontent, generates a physical effect: by absorbing water, the
ugars present in honey modify the surface osmotic pressure
n the wound, which mechanically prevents any bacteria
resent from adhering and proliferating and also reduces
ocal inﬂammation by promoting exudation. These biologi-
al effects provide ideal conditions for the development of
ranulation tissue and healing. In addition to these two fac-
ors, recent studies have demonstrated direct antibacterial
ffects for two components of honey: methylglycoxal (MGO)
nd a protein, bee-defensin 1 [8—10].
The various published in vitro studies analysing the local
ntibacterial activity of honey emphasize that:
this activity concerns a large number of bacteria
(Escherichia coli whether or not beta-lactamase
producing, Enterococcus whether or not vancomycin-
resistant, Staphylococcus aureus whether or not
methicillin-resistant, Pseudomonas aeruginosa whether
or not ciproﬂoxacin-resistant, Klebsiella pneumo-
niae, Enterobacter cloacae, Acinetobacter, and
Streptococcus);
the antibacterial activity of honey is 5- to 11-fold higher
than that obtained by application of sugar solutions,
thereby demonstrating that the antibacterial activity is
not simply due to the osmotic effect of its sugars [8—15].
The many in vitro studies that have compared various
ypes of honey emphasize variations in their respec-
ive hydrogen peroxide, MGO and bee-defensin 1 protein
oncentrations, with preferences very clearly inﬂuenced by
he author’s nationality. The current standard in terms of
oney is situated in the south hemisphere and Australian and
ew Zealand articles all conclude on the superior efﬁcacy of
heir honey, Manuka honey derived from an indigenous tree
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Table 2 The main types of medicinal honey marketed in the world.
Honey name Company name Country Price
Medihoney® MediHoney TM
Comvita Medical
Derma Sciences
Australia
New Zealand
USA
10D
L-Mesitran® Triticum Company Netherlands 13.59D
Activon® Advancis England 8.45D
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(Leptospermum scoparium). However, Irish authors con-
clude on the superiority of Chilean honey derived from the
Ulmo bush (Eucryphia cormen) compared to Manuka honey
[12]. In an Indian study from Madras, the authors concluded
on the superiority of the local honey (Khadikraft) com-
pared to Australian Manuka or British honey [13], while all
Malaysian authors highlight the advantages of Tualang honey
and Dutch authors report that Manuka honey does not con-
tain bee-defensin 1 protein [8,14]. All of these comparisons,
with unanimous conclusions concerning the healing and ther-
apeutic efﬁcacy of these various types of honey, are not
devoid of economic inﬂuences, as several medicinal hon-
eys are now available on the market (Table 2). The current
market of products intended for the treatment of wounds
is considerable. In the USA, in 2010, ﬁnancial reviews esti-
mated this market at 14 trillion dollars [16] and the North
American company Derma Sciences Inc. (Princeton, New Jer-
sey), specialized in skin care products, recently acquired a
Manuka honey-based paste approved by the Food and Drug
Administration for the treatment of wounds that it markets
under the brand name of Medihoney®.
It should also be emphasized that the presence of
proteins and polyphenols (caffeic acid, chrysin, galangin,
quercetin, apigenin, pinobanksin, pinocembrin, acacetin)
in honey also confers an antioxidant and potentially
antimitotic action. Several studies have demonstrated that
application of honey to the tumour site inhibited tumour
growth in vivo in mice and the growth of various cancer
cell lines in vitro [11,17,18], but no clinical study has yet
been conducted in man to conﬁrm this potential antitumour
action.
Therapeutic properties of honey
Honey is a food and topical application or ingestion of honey
for medicinal purposes treatments must be performed daily.
By topical application (Table 3), the wound is cleaned with
physiological saline and honey is then applied with a com-
press. Deep wounds can be ﬁlled to three quarters, then
covered with a dressing.
Three meta-analyses devoted to evaluation of the
healing properties of honey have been conducted over the
last 10 years. The ﬁrst two meta-analyses, published in
2001 and 2008, devoted to the beneﬁcial effects of honey
in burns and superﬁcial wounds and acute and chronic
wounds (venous, arterial, diabetic ulcers), concluded that
analysis of the studies published before 2000 and the
19 randomized studies published since 2000 did not formally
s
t
b
oNetherlands, Belgium,
England, Greece
On request
nd scientiﬁcally (due to the many, major methodologi-
al biases) demonstrate the superiority of honey, compared
o other treatments [7,19]. However, the authors also
eported that the results obtained with honey dressings
n terms of healing, infection control and sterilization are
ften superior to those obtained with conventional dress-
ngs with or without concomitant antibiotic therapy [7,19].
he most extensive experience of the use of honey in
he ﬁeld of wound healing was reported by a French sur-
eon from Limoges, Prof. Descottes. Based on a cohort
f more than 3000wounds, 94% of which corresponded to
ostoperative wound dehiscences, this author emphasized
he beneﬁts of honey (healing after failure of conventional
reatment, two-fold faster healing rate with than tulle gras
ressings, very good cosmetic quality of healing, 98% suc-
ess rate), and the low cost of the thyme honey used
20]. Visavidia et al. [21], in Great Britain, emphasized
he value of ﬁrst-line honey dressings on rapidly infected
ostoperative maxillofacial wounds in their everyday
linical practice. These published results are in line with our
xperience of the regular use of honey in our department
ince 1970, under the inﬂuence of Prof. Henri Laccourreye,
y twice daily topical application and regular oral ingestion
everal times a day, to treat salivary ﬁstula after head and
eck cancer surgery or for any healing problems after head
nd neck surgery. According to Ganacias-Acuna [22], honey
an also be combined with the use of negative pressure to
romote wound healing.
In the last meta-analysis published in 2008, devoted
o the role of honey in oncology, Bardy et al. [23] while
oncluding on the poor quality of the 40 or so stud-
es analysed due to various methodological problems,
lso emphasized that honey is as effective as usual
reatments for radiation mucositis, radiation dermatitis,
hemotherapy-induced hand-foot syndrome and/or post-
adiotherapy wounds of the skin or oral cavity. The efﬁcacy
f honey in radiation mucositis was recently conﬁrmed by
ashad et al. [24], who highlighted the efﬁcacy of honey in
revention of serious mucositis by topical application onto
he oral mucosa followed by ingestion of 20ml of honey
5minutes before, 15minutes after, and 6 hours after each
adiochemotherapy session (60—66Gray; 2 cGy/week; cis-
latin 20mg/m2 once a week).
Recurrent labial herpes lesions also appear to be very
ensitive to topical application of honey. In a randomized
tudy comparing honey application several times a day (four
imes daily for 15minutes) versus acyclovir (six times daily),
ased on analysis of the healing time, pain relief, resolution
f local signs and prevention of acute attacks, Al-Waili [25]
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Table 3 How to apply honey on a wound.
Clean the wound with physiological saline
Apply honey
Shallow wound: compress soaked in honey (30ml of honey for a 10× 10 cm compress)
Deep wound: directly ﬁll 3/4 of the wound with honey
Cover with an absorbent or occlusive dressing
Change the dressing once or twice a day (rinsing with physiological saline) until the appearance of granulation tissue, then
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oncluded on the signiﬁcant superiority of honey (P < 0.05)
nd attributed the therapeutic effect obtained to the pres-
nce of copper, ascorbic acid and hydrogen peroxide in
oney, which inactivate the Herpes simplex virus, and to
ocal inactivation of prostaglandins.
A last potential indication for honey appears to be cough
nd respiratory difﬁculties in children following upper res-
iratory tract infections. In a double-blind study conducted
n the United States in 2009 on 105 children comparing buck-
heat honey versus a classical dextromethorphan-based
ntitussive (Drill®, Humex®) and no treatment, the authors
oncluded on the superiority of honey in the treatment of
octurnal cough in children over the age of 1 year: less cough
nd better sleep for the child and the parents [26].
imitations and adverse effects of honey
ue to its acidic pH, honey can cause unpleasant or even
ainful feelings during application or ingestion that may
imit its use. In a study in rats comparing honey dressings
nd conventional dressings for the treatment of auricular
urns, Hashemi et al. [27] reported that the chondritis rate
as higher in the group treated with honey. The proximity of
artilage may, therefore, constitute a limiting factor to the
ealing efﬁcacy of honey. Similarly, according to Descottes
20], a history of local radiotherapy limits the healing
roperties of honey on skin wounds. Allergy to honey or its
ngredients and pollutants is extremely rare, but possible
1].
The main issue concerning the adverse effects of honey
oncerns the risk of botulism. Due to the presence of
lostridium botulinum spores (but not botulinum toxin)
n honey derived from many hives [5] and inactivation of
hese spores by low-dose gamma radiation (2 cGy) [6], it
s frequently recommended in the medical literature that
nly irradiated honey should be ingested and/or applied to
ounds. However, there are no published cases of botulism
n adults following the ingestion or topical application of
oney, despite the fact that the very great majority of
tudies on honey were conducted in developing or low-
ncome countries, in which gamma sterilization of honey is
ot performed. Similarly, in France, no cases of botulism
ere reported in the cohort published by Descottes [20] (in
hich honey does not appear to have been sterilized) or
n our own experience (in which a commercially available
ood honey has been used since 1970 to treat salivary ﬁs-
ula and/or wounds after neck surgery). Finally, the cases
f botulism reported in adults in France are not related to
ngestion of honey despite the fact that this product is exten-
ively used by the population [28]. However, several cases
C
Nf botulism related to honey have been reported in infants
nder the age of 1 year in the United States and France,
here the incidence of this disease has been increasing
ince 2000 [26,28,29]. In these cases, honey is ingested as
reatment or as a food supplement. Clostridium botulinum
hen proliferates in an immature gastro-intestinal system
nd produces botulinum toxin which subsequently induces
otulism. Honey, that has not been sterilized by gamma radi-
tion, should therefore not be used as a sweetener, food
ubstrate and/or in the context of medicinal ingestion in
nfants under the age of 1 year [26,28,29].
In the light of the published scientiﬁc data and the expe-
ience acquired over the last 30 years in Limoges, in Prof.
escottes’ Department of Surgery [20], and in Paris, in
he Department of Otorhinolaryngology and Head and Neck
urgery at Laënnec hospital and then, at the Georges Pompi-
ou European hospital (no cases of botulism reported after
pplication of honey to neck wounds, pharyngostome and/or
adiation mucositis), the food honey available in France
an, therefore, be used in patients over the age of 1 year
n otorhinolaryngology and head and neck surgery with no
edicolegal risks at the present time.
onclusion
n this age of budget restrictions and optimization of medical
esources, the research and development of effective and
nexpensive treatments constitute a major concern for all
linicians. In this context, application of honey to inﬂamed
ucosa and head and neck skin or mucosal wounds provides
real therapeutic beneﬁt. The local action of honey on
ultiresistant bacteria also participates in more effective
ntibiotic practices. The antitussive action of honey also
ppears to be useful in infants over the age of 1 year. The
ther properties (antioxidant and antimitotic) of systemic
dministration of honey need to be formally demonstrated
y in vivo studies, although many articles based on ani-
al experimentation and cell culture are in favour of these
ffects. None of the thousands of varieties of honey avail-
ble throughout the world appears to be truly superior.
arious countries, such as Australia and the United States
ave already developed the medicoeconomic use of this
roduct. When will a French medicinal honey be available?onﬂicts of interest statement
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